|

Understanding Mesothelioma: Causes, Symptoms, and Treatment

ByHolly Zink
Understanding Mesothelioma: Causes, Symptoms, and Treatment

Understanding the global impact of occupational asbestos exposure is critical. Data is important for implementing effective prevention and control measures.

A recent study assessed the burden of diseases caused by occupational asbestos exposure from 1990 to 2019, with a prediction for 2035. The study was published in BMC Public Health. Researchers show the trends in deaths and the years of life lost to disability from asbestos exposure. It highlights the need for continued efforts to address this occupational health risk.

Understanding the Impact of Asbestos

Mesothelioma is a type of cancer that affects the lining of the lungs, abdomen, or heart. Exposure to asbestos causes mesothelioma. Asbestos is a mineral that was once commonly used in construction and manufacturing. While mesothelioma is rare, it is important to understand its causes, symptoms, and treatment options.

Asbestos exposure is the cause of mesothelioma. When asbestos fibers are inhaled or ingested, they can become trapped in the body and cause inflammation and scarring over time. This can lead to the development of mesothelioma, often several decades after exposure. While the use of asbestos has declined in recent years, cases of mesothelioma continue to occur due to past exposure.

The symptoms of mesothelioma can vary depending on the location of the cancer. Pleural mesothelioma affects the lining of the lungs. Its symptoms may include chest pain, shortness of breath, and a persistent cough.

Peritoneal mesothelioma affects the lining of the abdomen. It can cause abdominal pain, swelling, and weight loss. And pericardial mesothelioma affects the heart’s lining. It can cause chest pain, palpitations, and trouble breathing.

Diagnosing mesothelioma can be hard. Its symptoms are like those of other conditions. But, if mesothelioma is suspected, doctors may do imaging tests, like X-rays or CT scans. They may also biopsy affected tissue for examination.

The options for treating mesothelioma depend on the cancer’s stage and the patient’s health. Surgery, chemotherapy, and radiation therapy are commonly used to treat mesothelioma. Surgeons may remove the cancer. Chemotherapy and radiation shrink and kill tumors and cancer cells. In some cases, a combination of these treatments may be used to improve outcomes.

Mesothelioma is a serious disease. It is often fatal. But, treatment advances have improved survival rates in recent years. But, finding the disease early is key to better outcomes. So, it is crucial for people who have been exposed to asbestos to watch their health. They should see a doctor if they have any symptoms of mesothelioma.

Mesothelioma is a rare but serious cancer that is caused by exposure to asbestos. It is important to understand its causes, symptoms, and treatments. This is key for finding it early and improving outcomes.

Source:

Miao, Xinlu, Teng Yao, Chenxian Dong, Zuhai Chen, Wanting Wei, Zhengyang Shi, Tongtong Xu, et al. “Global, Regional, and National Burden of Non-Communicable Diseases Attributable to Occupational Asbestos Exposure 1990-2019 and Prediction to 2035: Worsening or Improving?” BMC Public Health 24, no. 1 (March 18, 2024): 832. https://doi.org/10.1186/s12889-024-18099-4.

 

 

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    ByAlex Strauss

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…